This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States 1973-2002. JAMA. 2006; 295(18): 2164-2167.DaviesLWelchHGIncreasing incidence of thyroid cancer in the United States 1973-20022006295182164216710.1001/jama.295.18.216416684987Search in Google Scholar
Akulevich NM, Saenko VA, Rogounovitch TI, Drozd VM, Lushnikov EF, Ivanov VK, et al. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Endocr Relat Cancer. 2009; 16(2): 491-503.AkulevichNMSaenkoVARogounovitchTIDrozdVMLushnikovEFIvanovVKet alPolymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma200916249150310.1677/ERC-08-033619286843Search in Google Scholar
Lence-Anta JJ, Xhaard C, Ortiz RM, Kassim H, Pereda CM, Turcios S, et al. Environmental, lifestyle, and anthropometric riskfactors for differentiated thyroid cancer in cuba: a case-control study. Eur Thyroid J. 2014; 3(3): 189-196.Lence-AntaJJXhaardCOrtizRMKassimHPeredaCMTurciosSet alEnvironmental, lifestyle, and anthropometric riskfactors for differentiated thyroid cancer in cuba: a case-control study201433189196Search in Google Scholar
Bashir K, Sarwar R, Fatima S, Saeed S, Mahjabeen I, Akhtar Kayani M. Haplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma. J BUON. 2018; 23(1): 234-243.BashirKSarwarRFatimaSSaeedSMahjabeenIAkhtarKayani MHaplotype analysis of XRCC1 gene polymorphisms and the risk of thyroid carcinoma2018231234243Search in Google Scholar
Matsuse M, Mitsutake N, Tanimura S, Ogi T, Nishihara E, Hirokawa M, et al. Functional characterization of the novel BRAF complexmutation, BRAF (V600 delinsYM), identified in papillarythyroid carcinoma. Int J Cancer. 2013; 132(3): 738-743.MatsuseMMitsutakeNTanimuraSOgiTNishiharaEHirokawaMet alFunctional characterization of the novel BRAF complexmutation, BRAF (V600 delinsYM), identified in papillarythyroid carcinoma2013132373874310.1002/ijc.2770922752848Search in Google Scholar
Hu Z, Hu X, Long J, Su L, Wei B. XRCC1 polymorphisms and differentiated thyroid carcinoma risk: A meta-analysis. Gene. 2013; 528(2): 67-73.HuZHuXLongJSuLWeiBXRCC1 polymorphisms and differentiated thyroid carcinoma risk: A meta-analysis20135282677310.1016/j.gene.2013.07.00523872202Search in Google Scholar
Du Y, Han LY, Li DD, Liu H, Gao YH, Sun D. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: A meta-analysis. Asian Pac J Cancer Prev. 2013; 14(9): 5483-5487.DuYHanLYLiDDLiuHGaoYHSunDAssociations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: A meta-analysis20131495483548710.7314/APJCP.2013.14.9.548324175846Search in Google Scholar
Chang-Claud J, Popanda O, Tan XL, Kropp S, Helmbold I, von Fournier D, et al. Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res. 2005; 11(13): 4802-4809.Chang-ClaudJPopandaOTanXLKroppSHelmboldIvonFournier Det alAssociation between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients200511134802480910.1158/1078-0432.CCR-04-265716000577Search in Google Scholar
Zhai W, Feng R, Wang H, Wang Y. Note of clarification of data in the papertitled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: An updated meta-analysis. Tumour Biol. 2015; 36(5): 3179-3189.ZhaiWFengRWangHWangYNote of clarification of data in the papertitled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: An updated meta-analysis20153653179318910.1007/s13277-015-3384-425835974Search in Google Scholar
Bu T, Liu L, Sun Y, Zhao L, Peng Y, Zhou S, et al. XRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: A meta-analysis of 10846 cases and 11723 controls. PLoS One. 2014; 9(1): e86086.BuTLiuLSunYZhaoLPengYZhouSet alXRCC1 Arg399Gln polymorphism confers risk of breast cancer in American population: A meta-analysis of 10846 cases and 11723 controls201491e8608610.1371/journal.pone.0086086390484824489692Search in Google Scholar
Tian Z, Li YL, Liu JG. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population. Mol Biol Rep. 2013; 40(7): 4147-4151.TianZLiYLLiuJGXRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population20134074147415110.1007/s11033-012-2463-523712778Search in Google Scholar
Ho T, Li G, Lu J, Zhao C, Wei Q, Sturgis EM. Association of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: A case-control analysis. Thyroid. 2009; 19(2): 129-135.HoTLiGLuJZhaoCWeiQSturgisEMAssociation of XRCC1 polymorphisms and risk of differentiated thyroid carcinoma: A case-control analysis200919212913510.1089/thy.2008.015319191745Search in Google Scholar
Chiang FY, Wu CW, Hsiao PJ, Kuo WR, Lee KW, Lin LC, et al. Association between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma. Clin Cancer Res. 2008; 14(18): 5919-5924.ChiangFYWuCWHsiaoPJKuoWRLeeKWLinLCet alAssociation between polymorphisms in DNA base excision repair genes XRCC1, APE1, and ADPRT and differentiated thyroid carcinoma200814185919592410.1158/1078-0432.CCR-08-0906Search in Google Scholar
Garcia-Quispes WA, Perez-Machado G, Akdi A, Pastor S, Galofre P, Biarnes F, et al. Association studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer. Mutat Res. 2011: 709-710: 67-72.Garcia-QuispesWAPerez-MachadoGAkdiAPastorSGalofrePBiarnesFet alAssociation studies of OGG1, XRCC1, XRCC2 and XRCC3 polymorphisms with differentiated thyroid cancer2011709-710677210.1016/j.mrfmmm.2011.03.003Search in Google Scholar
Zhu QX, Bian JC, Shen Q, Pastor S, Galofré P, Zhang HW, et al. Genetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma. Zhonghua Liu Xing Bing Xue Za Zhi. 2004; 25(8): 702-705.ZhuQXBianJCShenQPastorSGalofréPZhangHWet alGenetic polymorphisms in X-ray repair cross-complementing gene 1 and susceptibility to papillary thyroid carcinoma2004258702705Search in Google Scholar
Ryu RA, Tae K, Min HJ, Jeong JH, Cho SH, Lee SH, et al. XRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample. J Korean Med Sci. 2011; 26(8): 991-995.RyuRATaeKMinHJJeongJHChoSHLeeSHet alXRCC1 polymorphisms and risk of papillary thyroid carcinoma in a Korean sample201126899199510.3346/jkms.2011.26.8.991Search in Google Scholar
Zhu J, Qi P, Li Z. Interaction between XRCC1 gene polymorphisms and obesity on susceptibility to papillary thyroid cancer in Chinese Han population. Cell Physiol Biochem. 2018; 49(2): 638-644.ZhuJQiPLiZInteraction between XRCC1 gene polymorphisms and obesity on susceptibility to papillary thyroid cancer in Chinese Han population201849263864410.1159/000493027Search in Google Scholar
Sigurdson AJ, Land CE, Bhatti P, Pineda M, Brenner A, Carr Z, et al. Thyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan. Radiat Res. 2009; 171(1): 77-88.SigurdsonAJLandCEBhattiPPinedaMBrennerACarrZet alThyroid nodules, polymorphic variants in DNA repair and RET-related genes, and interaction with ionizing radiation exposure from nuclear tests in Kazakhstan20091711778810.1667/RR1327.1Search in Google Scholar
Wang X, Zhang K, Liu X, Liu B, Wang Z. Association between XRCC1 and XRCC3 gene polymorphisms and risk of thyroid cancer. Int J Clin Exp Pathol. 2015; 8(3): 3160-3167.WangXZhangKLiuXLiuBWangZAssociation between XRCC1 and XRCC3 gene polymorphisms and risk of thyroid cancer20158331603167Search in Google Scholar
Wang C, Ai Z. Association of XRCC1 polymorphisms with thyroid cancer risk. Tumour Biol. 2014;35:4791-7.WangCAiZAssociation of XRCC1 polymorphisms with thyroid cancer risk2014354791710.1007/s13277-014-1629-2Search in Google Scholar
Yan L, Li Q, Li X, Ji H, Zhang L. Association studies between XRCC1, XRCC2, XRCC3 polymorphisms and differentiated thyroid carcinoma. Cell Physiol Biochem. 2016; 38(3): 1075-1084.YanLLiQLiXJiHZhangLAssociation studies between XRCC1, XRCC2, XRCC3 polymorphisms and differentiated thyroid carcinoma20163831075108410.1159/000443058Search in Google Scholar
Fan J, Otterlei M, Wong HK, Tomkinson AE, Wilson DM 3rd. XRCC1 co-localizes and physically interacts with PCNA. Nucleic Acid Res. 2004; 32(7): 21932201.FanJOtterleiMWongHKTomkinsonAEWilsonDM 3rdXRCC1 co-localizes and physically interacts with PCNA20043272193220110.1093/nar/gkh556Search in Google Scholar
Caldecott KW. XRCC1 and DNA strand repair. DNA Repair (Amst). 2003; 2(9): 955-969.CaldecottKWXRCC1 and DNA strand repair20032995596910.1016/S1568-7864(03)00118-6Search in Google Scholar
Hung RJ, Hall J, Brennan P, Boffetta P. Genetic polymorphism in the base excision repair pathway and cancer risk. A HuGE review. Am J Epidemiol. 2005; 162(10): 925-942.HungRJHallJBrennanPBoffettaPGenetic polymorphism in the base excision repair pathway and cancer risk20051621092594210.1093/aje/kwi31816221808Search in Google Scholar
Yan L, Yanan D, Donglan S, Na W, Rongmiao Z, Zhifeng C. Polymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma. Dis Esophagus. 2009; 22(5): 396-401.YanLYananDDonglanSNaWRongmiaoZZhifengCPolymorphisms of XRCC1 gene and risk of gastric cardiac adenocarcinoma200922539640110.1111/j.1442-2050.2008.00912.x19673050Search in Google Scholar
Takanami T, Nakamura J, Kubota Y, Horiuchi S. The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repairability. Mutat Res. 2005; 582(1-2): 135-145.TakanamiTNakamuraJKubotaYHoriuchiSThe Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repairability20055821-213514510.1016/j.mrgentox.2005.01.00715781218Search in Google Scholar
Zhang K, Zhou B, Wang Y, Rao L, Zhang L. The XRCC1 Arg280His polymorphism contributes to cancer susceptibility: An update by meta-analysis of 53 individual studies. Gene. 2012; 510(2): 93-101.ZhangKZhouBWangYRaoLZhangLThe XRCC1 Arg280His polymorphism contributes to cancer susceptibility: An update by meta-analysis of 53 individual studies201251029310110.1016/j.gene.2012.08.03922975644Search in Google Scholar
Qian K, Liu KJ, Xu F, Chen XY, Chen GN, Yi WJ, et al. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and thyroid carcinoma risk: A meta-analysis. Asian Pac J Cancer Prev. 2012; 13(12): 6385-6390.QianKLiuKJXuFChenXYChenGNYiWJet alX-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and thyroid carcinoma risk: A meta-analysis201213126385639010.7314/APJCP.2012.13.12.638523464463Search in Google Scholar
Yang D, Han L-Y, Li D-D, Liu H, Gao YH, Sun DJ. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: A meta-analysis. Asian Pac J Cancer Prev. 2013; 14(9): 5483-5487.YangDHanL-YLiD-DLiuHGaoYHSunDJAssociations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: A meta-analysis20131495483548710.7314/APJCP.2013.14.9.548324175846Search in Google Scholar
Hu Z, Hu X, Long J, Su L, Wei B. XRCC1 poly-morphisms and differentiated thyroid carcinoma risk: A meta-analysis. Gene. 2013; 528(2): 67-73.HuZHuXLongJSuLWeiBXRCC1 poly-morphisms and differentiated thyroid carcinoma risk: A meta-analysis20135282677310.1016/j.gene.2013.07.00523872202Search in Google Scholar
Bao Y, Jiang L, Zhou JY, Zou JJ, Zheng JY, Chen XF, et al. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): A meta-analysis of case-control studies. PLos One. 2013; 8(5): e64851.BaoYJiangLZhouJYZouJJZhengJYChenXFet alXRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): A meta-analysis of case-control studies201385e6485110.1371/journal.pone.0064851366146823717668Search in Google Scholar
Wang C, Ai Z. Association of XRCC1 polymorphisms with thyroid cancer risk. Tumor Biol. 2014; 35(5): 4791-4797.WangCAiZAssociation of XRCC1 polymorphisms with thyroid cancer risk20143554791479710.1007/s13277-014-1629-224477575Search in Google Scholar
Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, et al. Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2003; 12(4): 359-365.ZhouWLiuGMillerDPThurstonSWXuLLWainJCet alPolymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking and lung cancer risk2003124359365Search in Google Scholar
Dailey ME, Lindsay S, Skahen R. Relation of thyroid neoplasms to Hashimoto disease of the thyroid gland. Arch Surg. 1955; 70(2): 291-297.DaileyMELindsaySSkahenRRelation of thyroid neoplasms to Hashimoto disease of the thyroid gland195570229129710.1001/archsurg.1955.0127008013702313227748Search in Google Scholar
Cheema Y, Olson S, Elson D, Chen H. What is the biology and optimal treatment for papillary micro-carcinoma of the thyroid? J Surg Res. 2006; 134(2): 160-162.CheemaYOlsonSElsonDChenHWhat is the biology and optimal treatment for papillary micro-carcinoma of the thyroid?2006134216016210.1016/j.jss.2006.04.01416780882Search in Google Scholar
Jankovic B, Le KT, Hershman JM. Clinical Review: Hashimoto’s thyroiditis and papillary thyroid carcinoma: Is there a correlation? J Clin Endocrinol Metab. 2013; 98(2): 474-482.JankovicBLeKTHershmanJMClinical Review: Hashimoto’s thyroiditis and papillary thyroid carcinoma: Is there a correlation?201398247448210.1210/jc.2012-297823293329Search in Google Scholar